Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mott

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|March 15, 2018
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5AJohn R Horton, Xu Liu, Lizhen Wu, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Cell Metabolism|February 9, 2016
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung CancerShawn M Davidson, Thales Papagiannakopoulos, Benjamin A Olenchock, et al.
Cell Chemical Biology|July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse CompoundsJohn R Horton, Xu Liu, Molly Gale, et al.
Plos Biology|August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STINGLizhen Wu, Jian Cao, Wesley L Cai, et al.
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenasePlamen P Christov, Kwangho Kim, Somnath Jana, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|March 15, 2018
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5AJohn R Horton, Xu Liu, Lizhen Wu, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Cell Metabolism|February 9, 2016
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung CancerShawn M Davidson, Thales Papagiannakopoulos, Benjamin A Olenchock, et al.
Cell Chemical Biology|July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse CompoundsJohn R Horton, Xu Liu, Molly Gale, et al.
Plos Biology|August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STINGLizhen Wu, Jian Cao, Wesley L Cai, et al.
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenasePlamen P Christov, Kwangho Kim, Somnath Jana, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Pageof 12